del Junco D, Luthra H S, Annegers J F, Worthington J W, Kurland L T
Am J Epidemiol. 1984 May;119(5):813-29. doi: 10.1093/oxfordjournals.aje.a113802.
This investigation of the familial aggregation of rheumatoid arthritis in Rochester, Minnesota, was prompted by the considerable variability in previous reports and the need to interpret findings in light of the recently established human lymphocyte antigen (HLA)-DR4 association. The historical cohort methodology was applied to determine the incidence of adult-onset rheumatoid arthritis in 1631 biologic relatives of 78 probands compared with the Rochester population incidence. The ratio of the age- and sex-adjusted rates in first-degree relatives compared with the general population was 1.7 (95% confidence interval 1.0-2.9). The increase was concentrated in the 16- to 40-year-old age group, suggesting some disease heterogeneity. However, the level of familial risk was not significantly affected by the proband's sex, seropositivity, age, or parental disease status. Integrating these findings with prior research in which case ascertainment was complete led to the conclusion that familial aggregation of rheumatoid arthritis is weak. The apparent discrepancy between weak familial aggregation and the known strong HLA-DR4 association with rheumatoid arthritis was resolved by examining the mathematical relationship between the measures of association in the two different types of studies. Results show that to be consistent with weak familial clustering, any putative susceptibility gene must have very low penetrance, and/or there must be a large residual of sporadic cases.
明尼苏达州罗切斯特市对类风湿性关节炎家族聚集性的这项调查,是由先前报告中存在的显著差异以及根据最近确立的人类淋巴细胞抗原(HLA)-DR4关联来解释研究结果的需求所推动的。采用历史队列研究方法来确定78名先证者的1631名生物学亲属中成人发病类风湿性关节炎的发病率,并与罗切斯特市人群发病率进行比较。与普通人群相比,一级亲属中经年龄和性别调整后的发病率之比为1.7(95%置信区间1.0 - 2.9)。发病率的增加集中在16至40岁年龄组,提示存在一定的疾病异质性。然而,家族风险水平并未受到先证者的性别、血清学阳性、年龄或父母疾病状况的显著影响。将这些发现与先前病例确诊完整的研究相结合,得出类风湿性关节炎家族聚集性较弱的结论。通过研究两种不同类型研究中关联度测量之间的数学关系,解决了家族聚集性较弱与已知的类风湿性关节炎与HLA - DR4强关联之间明显的差异。结果表明,要与较弱的家族聚集性一致,任何假定的易感基因的外显率必须非常低,和/或散发病例的剩余比例必须很大。